期刊
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
卷 69, 期 1, 页码 -出版社
SPRINGER BASEL AG
DOI: 10.1007/s00005-021-00631-8
关键词
Bone marrow cells transplantation; Cells supportive therapy; Immunoprivileged compartments; Vascularized composite allotransplantation; Groin flap
类别
资金
- Department of Defense Armed Forces Institute of Regenerative Medicine (AFIRM) [W81XWH-08-2-0034]
The study compared the tolerogenic effects of different allogeneic bone marrow transplantation delivery routes into immunoprivileged compartments under suppressive therapy, finding that intrathecal BMT resulted in the longest allograft survival and higher levels of CD4(+)/CD25(+) T cells in the peripheral blood. This transplantation method delayed rejection of fully mismatched VSA and induced robust, donor-specific chimerism.
Using the vascularized skin allograft (VSA) model, we compared the tolerogenic effects of different allogeneic bone marrow transplantation (BMT) delivery routes into immunoprivileged compartments under a 7-day protocol immunosuppressive therapy. Twenty-eight fully MHC mismatched VSA transplants were performed between ACI (RT1(a)) donors and Lewis (RT1(1)) recipients in four groups of seven animals each, under a 7-day protocol of alfa/beta TCRmAb/CsA (alpha/beta-TCR monoclonal antibodies/Cyclosporine A therapy). Donor bone marrow cells (BMC) (100 x 106 cells) were injected into three different immunoprivileged compartments: Group 1: Control, without cellular supportive therapy, Group 2: Intracapsular BMT, Group 3: Intragonadal BMT, Group 4: Intrathecal BMT. In Group 2, BMC were transplanted under the kidney capsule. In Group 3, BMC were transplanted into the right testis between tunica albuginea and seminiferous tubules, and in Group 4, cells were injected intrathecally. The assessment included: skin evaluation for signs and grade of rejection and immunohistochemistry for donor cells engraftment into host lymphoid compartments. Donor-specific chimerism for MHC class I (RT1(a)) antigens and the presence of CD4(+)/CD25(+) T cells were assessed in the peripheral blood of recipients. The most extended allograft survival, 50-78 days, was observed in Group 4 after intrathecal BMT. The T cells CD4(+)/CD25(+) in the peripheral blood were higher after intrathecal BMC injection than other experimental groups at each post-transplant time point. Transplantation of BMC into immunoprivileged compartments delayed rejection of fully mismatched VSA and induction of robust, donor-specific chimerism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据